Syngene International's Q3 FY 2025-26 Quarterly Results
- 23 Jan 2026
Result Summary
- Syngene International Ltd reported a 0.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 3.1%.
- Its expenses for the quarter were down by 0.9% QoQ and up 6.7% YoY.
- The net profit decreased 77.6% QoQ and decreased 88.6% YoY.
- The earnings per share (EPS) of Syngene International Ltd stood at 0.37 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 932.50 | 926.00 | 962.00 | 0.7% | -3.1% |
Total Expenses | 833.50 | 840.80 | 781.20 | -0.9% | 6.7% |
Profit Before Tax | 28.40 | 85.20 | 180.80 | -66.7% | -84.3% |
Tax | 13.40 | 18.10 | 49.70 | -26.0% | -73.0% |
Profit After Tax | 15.00 | 67.10 | 131.10 | -77.6% | -88.6% |
Earnings Per Share | 0.37 | 1.67 | 3.26 | -77.8% | -88.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Syngene International Ltd is a leading contract research and manufacturing services company, serving the pharmaceutical, biotechnology, and agrochemical industries. The company provides integrated services in drug discovery, development, and manufacturing. It operates in a highly competitive sector, with a focus on delivering innovative solutions to its clients. Syngene's business is anchored on its scientific expertise, state-of-the-art infrastructure, and a commitment to quality and compliance. As of the latest information available up to October 2023, no significant major developments have been outlined.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Syngene International Ltd reported a total income of ₹932.50 crores. This reflects a modest quarter-over-quarter (QoQ) increase of 0.7% from ₹926.00 crores in Q2FY26. However, when compared to the third quarter of the previous fiscal year (Q3FY25), there is a year-over-year (YoY) decline of 3.1% from ₹962.00 crores. The revenue figures indicate slight growth on a quarterly basis but a decrease when viewed annually.
Profitability
Syngene International Ltd's profitability metrics for Q3FY26 demonstrate a significant decline. The company reported a profit before tax of ₹28.40 crores, marking a sharp decrease of 66.7% QoQ from ₹85.20 crores in Q2FY26 and an 84.3% YoY decline from ₹180.80 crores in Q3FY25. The tax expense for Q3FY26 was ₹13.40 crores, a reduction of 26.0% from the previous quarter and 73.0% compared to the same quarter last year. Consequently, the profit after tax stood at ₹15.00 crores, showing a 77.6% QoQ drop from ₹67.10 crores and an 88.6% YoY decrease from ₹131.10 crores. Earnings per share also fell significantly to ₹0.37 in Q3FY26, down 77.8% QoQ and 88.7% YoY.
Operating Metrics
The financial data for Syngene International Ltd in Q3FY26 highlights a reduction in total expenses, which decreased by 0.9% QoQ to ₹833.50 crores from ₹840.80 crores in Q2FY26. However, there is a 6.7% YoY increase in expenses from ₹781.20 crores in Q3FY25. This indicates changes in operational costs over the specified periods. Key financial ratios such as the P/E ratio, debt-to-equity ratio, or current ratio are not directly calculable from the provided dataset. The trends in expenses alongside the revenue and profitability metrics suggest variations in the company’s operational efficiency or cost structure.